Walleye Trading LLC Puma Biotechnology, Inc. Call Options Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $64,056 - $148,614	-10,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $34,450 - $56,869	5,300 Added 108.16%	10,200 $89,000
Q3 2019 Nov 14, 2019	SELL	$8.75 - $12.85 $351,750 - $516,570	-40,200 Reduced 89.14%	4,900 $53,000
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $456,330 - $1.33 Million	37,100 Added 463.75%	45,100 $573,000
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $6,231 - $12,711	300 Added 3.9%	8,000 $310,000
Q4 2018 Feb 14, 2019	BUY	$20.07 - $46.7 $140,490 - $326,900	7,000 Added 1000.0%	7,700 $157,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $28,840 - $41,895	700 New	700 $32,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $154M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.